Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Protection against oxidative stress-induced cell death by intracellular platelet-activating factor-acetylhydrolase II.

Matsuzawa A, Hattori K, Aoki J, Arai H, Inoue K.

J Biol Chem. 1997 Dec 19;272(51):32315-20.

2.

Platelet-activating factor (PAF)-dependent transacetylase and its relationship with PAF acetylhydrolases.

Bae K, Longobardi L, Karasawa K, Malone B, Inoue T, Aoki J, Arai H, Inoue K, Lee T.

J Biol Chem. 2000 Sep 1;275(35):26704-9.

3.

cDNA cloning and expression of intracellular platelet-activating factor (PAF) acetylhydrolase II. Its homology with plasma PAF acetylhydrolase.

Hattori K, Adachi H, Matsuzawa A, Yamamoto K, Tsujimoto M, Aoki J, Hattori M, Arai H, Inoue K.

J Biol Chem. 1996 Dec 20;271(51):33032-8.

4.

Platelet-activating factor acetylhydrolase.

Arai H.

Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:83-94. Review.

PMID:
12432911
5.

Protection against oxidative stress-induced hepatic injury by intracellular type II platelet-activating factor acetylhydrolase by metabolism of oxidized phospholipids in vivo.

Kono N, Inoue T, Yoshida Y, Sato H, Matsusue T, Itabe H, Niki E, Aoki J, Arai H.

J Biol Chem. 2008 Jan 18;283(3):1628-36.

6.

Platelet-activating factor acetylhydrolase (PAF-AH).

Arai H, Koizumi H, Aoki J, Inoue K.

J Biochem. 2002 May;131(5):635-40. Review.

7.

Purification and characterization of platelet-activating factor acetylhydrolase II from bovine liver cytosol.

Hattori K, Hattori M, Adachi H, Tsujimoto M, Arai H, Inoue K.

J Biol Chem. 1995 Sep 22;270(38):22308-13.

8.

Identification of platelet-activating factor acetylhydrolase II in human skin.

Marques M, Pei Y, Southall MD, Johnston JM, Arai H, Aoki J, Inoue T, Seltmann H, Zouboulis CC, Travers JB.

J Invest Dermatol. 2002 Oct;119(4):913-9.

9.
10.

Human platelets secrete the plasma type of platelet-activating factor acetylhydrolase primarily associated with microparticles.

Mitsios JV, Vini MP, Stengel D, Ninio E, Tselepis AD.

Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1907-13.

11.
12.

Plasma platelet activating factor-acetylhydrolase (PAF-AH).

Karasawa K, Harada A, Satoh N, Inoue K, Setaka M.

Prog Lipid Res. 2003 Mar;42(2):93-114. Review.

PMID:
12547653
13.

Overview of PAF-Degrading Enzymes.

Karasawa K, Inoue K.

Enzymes. 2015;38:1-22. doi: 10.1016/bs.enz.2015.09.006.

PMID:
26612643
14.

Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.

Watson AD, Navab M, Hama SY, Sevanian A, Prescott SM, Stafforini DM, McIntyre TM, Du BN, Fogelman AM, Berliner JA.

J Clin Invest. 1995 Feb;95(2):774-82.

15.

Molecular basis for susceptibility of plasma platelet-activating factor acetylhydrolase to oxidative inactivation.

MacRitchie AN, Gardner AA, Prescott SM, Stafforini DM.

FASEB J. 2007 Apr;21(4):1164-76.

17.

Platelet-activating factor acetylhydrolase isoforms I and II in human uterus. Comparisons with pregnant uterus and myoma.

Yasuda K, Okumura T, Okada H, Nakajima T, Aoki J, Arai H, Inoue K, Nishizawa M, Ito S, Kanzaki H.

Biol Reprod. 2001 Jan;64(1):339-44.

19.

Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population.

Yamada Y, Yoshida H, Ichihara S, Imaizumi T, Satoh K, Yokota M.

Atherosclerosis. 2000 May;150(1):209-16.

PMID:
10781653
20.

Regulating inflammation through the anti-inflammatory enzyme platelet-activating factor-acetylhydrolase.

Castro Faria Neto HC, Stafforini DM, Prescott SM, Zimmerman GA.

Mem Inst Oswaldo Cruz. 2005 Mar;100 Suppl 1:83-91.

Items per page

Supplemental Content

Support Center